Elite Pharms Inc (OP:ELTP)

0.3620 UNCHANGED

Streaming Delayed Price Updated: 3:57 PM EDT, Jun 23, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	0.3620
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.3620
Today's Range	0.3620 - 0.3620
52wk Range	0.3252 - 0.7986
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

June 16, 2025

Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company...

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets

April 30, 2025

Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical...

Via Newsfile

Performance

YTD	-27.6%	-27.6%
1 Month	+4.4%	+4.4%
3 Month	-4.2%	-4.2%
6 Month	-24.6%	-24.6%
1 Year	-51.7%	-51.7%

More News

Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line

March 03, 2025

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information

February 13, 2025

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information

February 14, 2024

Via ACCESSWIRE

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025

February 10, 2025

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

December 26, 2024

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets

December 02, 2024

Via Newsfile

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse

November 18, 2024

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

November 14, 2024

Via Newsfile

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024

November 07, 2024

Via Newsfile

Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health

October 10, 2024

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets

October 07, 2024

Via Newsfile

Top Analyst Reports For Nvidia, American Express & Wells Fargo ↗

September 27, 2024

Via Talk Markets

Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium

August 27, 2024

Via Newsfile

ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q1 2025 ↗

August 14, 2024

Via InvestorPlace

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information

August 14, 2024

Via Newsfile

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024

August 09, 2024

Via Newsfile

ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q4 2024 ↗

July 11, 2024

Via InvestorPlace

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information

July 01, 2024

Via Newsfile

Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet ↗

June 27, 2024

Via InvestorPlace

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024

June 26, 2024

Via Newsfile

7 Strong Buy Penny Stocks to Buy Now: June 2024 ↗

June 13, 2024

Via InvestorPlace

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

May 20, 2024

Via ACCESSWIRE

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024

February 08, 2024

Via ACCESSWIRE

Frequently Asked Questions

Is Elite Pharms Inc publicly traded?

Yes, Elite Pharms Inc is publicly traded.

What exchange does Elite Pharms Inc trade on?

Elite Pharms Inc trades on the OTC Traded

What is the ticker symbol for Elite Pharms Inc?

The ticker symbol for Elite Pharms Inc is ELTP on the OTC Traded

What is the current price of Elite Pharms Inc?

The current price of Elite Pharms Inc is 0.3620

When was Elite Pharms Inc last traded?

The last trade of Elite Pharms Inc was at 06/23/26 03:57 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.